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Objective: To evaluate whether amniotic fluid markers can aid the decision of whether to retain or remove a
cervical cerclage after preterm premature rupture of membranes (PPROM). Methods: A retrospective cohort
study included pregnancies involving PPROM after diagnostic amniocentesis and cerclage placement. Cerclage
was retained formore than 12 hours after PPROM in the study group (n = 18); the comparison group comprised
women who underwent immediate cerclage removal after PPROM (n = 22). Analyses were performed using
concentrations of interleukin (IL)-6, glucose, and white blood cells (WBCs) in the amniotic fluid to measure re-
lationships with adverse outcomes. Results: The latency period from PPROM to delivery was significantly shorter
in the group that underwent immediate cerclage removal (P b 0.005). Latency periods of more than 48 hours
(P b 0.001) and more than 7 days (P b 0.01), and chorioamnionitis (P b 0.05) were associated with cerclage re-
tention. Neonatal outcomeswere not significantly different between the study group and the comparison group.
However, elevated IL-6 levels were associated with cumulative neonatal morbidity (P b 0.05). Low IL-6
(P b 0.001) and WBC (P b 0.05) levels were significantly associated with a latency period of more than 7 days.
Conclusion: Amniotic fluid levels of IL-6 and WBCs may be of clinical value for individualizing the management
of patients with PPROM after cerclage.Published by Elsevier Ireland Ltd. on behalf of International Federation of Gynecology and Obstetrics.1. Introduction
Cervical cerclage is a procedure performed worldwide to improve
outcomes in settings involving prematurity. Pretermpremature rupture
of membranes (PPROM) is a common complication that has been
reported in 38% of patients with a cervical cerclage in place [1]. The po-
tential benefit of cerclage retention—which prolongs the latency period
between PPROM and delivery, and decreases complications related to
prematurity—must be balanced with the risk of adverse neonatal out-
comes related to infection. Although cerclage is used in only 0.4% of
pregnancies in the USA [2], 11.4% of patients with a diagnosis of
PPROM have a cerclage in place [3]. The management of PPROM is rela-
tively well established in the absence of cerclage but limited data are
available from studies regarding the management of PPROM when a
cerclage is in place. Controversy remains regarding the decision on
whether to retain the cerclage or remove it. Some studies have shown
increased intrauterine infection risks and increased neonatal morbiditys and Gynecology, Division of
oigtlander Women’s Hospital,
8109, USA. Tel.: +1 248 224
tmail.com (E. Aguin).
and Ltd. on behalf of International Fewith cerclage retention [4,5], while others have not demonstrated such
a difference in maternal and perinatal outcomes, supporting prolonged
latency with cerclage retention after PPROM [6,7]. These conflicting re-
sults indicate the need for amore individualized intervention on a case-
by-case basis among patients with PPROM after cerclage placement.
Inflammatory markers in amniotic fluid are predictive of neonatal
outcomes in cases of preterm labor with intact membranes. The data
are more limited regarding the significance of such markers in cases
of PPROM [8]. In a previous study, we analyzed the association of amni-
otic fluid markers with success rates of cervical cerclage [9]. The aim of
the present study was to evaluate whether amniocentesis plus mea-
surement of amniotic fluid markers can aid in the decision to retain or
remove a cervical cerclage after PPROM. We hypothesized that the
concentration of inflammatory markers—including interleukin (IL)-6,
glucose, and white blood cells (WBCs)—in amniotic fluid can be used
to distinguish cases that would benefit from retaining or removing the
cerclage in the presence of PPROM.2. Materials and methods
A retrospective cohort study was conducted involving women who
presented with PPROM after diagnostic amniocentesis and cervicalderation of Gynecology and Obstetrics.
Table 1
Demographic characteristics.a
Characteristic Removal
(n = 22)
Retention
(n = 18)
P value
Maternal age, y 26.41 ± 5.09 28.50 ± 5.58 0.224
Gravidity (per patient) 3.50 ± 2.04 3.83 ± 1.79 0.591
Full-term parity (per patient) 0.18 ± 0.50 0.17 ± 0.38 0.917
Previous preterm delivery (per patient) 1.77 ± 1.11 2.06 ± 1.16 0.437
Gestational age at time of cerclage, wk 20.19 ± 2.32 19.96 ± 1.72 0.725
Gestational age at time of amniocentesis, wk 19.87 ± 2.42 19.54 ± 2.05 0.655
Gestational age at time of PPROM, wk 27.23 ± 5.33 26.94 ± 5.01 0.858
Maternal body mass indexb 34.53 ± 8.05 31.68 ± 8.64 0.290
Maternal cervical length, mm 14.07 ± 10.50 12.82 ± 11.74 0.717
Abbreviation: PPROM, preterm premature rupture of membranes.
a Values are given as mean ± SD unless otherwise indicated.
b Calculated as weight in kilograms divided by the square of height in meters.
Table 2
Concentration of inflammatory markers in amniotic fluid.a
Marker Removal (n = 22) Retention (n = 18) P value
Interleukin-6, ng/mL 26.14 ± 33.52 17.64 ± 26.38 0.387
White blood cells, cells/mm3 21.00 ± 28.23 8.39 ± 17.20 0.106
Glucose, mg/dL 36.45 ± 24.93 30.78 ± 7.39 0.358
a Values are given as mean ± SD unless otherwise indicated.
Table 3
Pregnancy outcomes.a
Outcome Removal (n = 22) Retention (n = 18) P value
Gestational age at time of
delivery, wk
27.19 ± 5.32 25.68 ± 7.09 0.349
Latency period from PPROM
to delivery, d
0.64 ± 1.43 6.50 ± 7.09 0.003
Latency period of N48 hours 2 (9.1) 11 (61.1) b0.001
Latency period of N7 days 1 (2.5) 6 (31.7) 0.008
Histologic chorioamnionitis 13 (59.1) 18 (100.0) 0.016
Abbreviation: PPROM, preterm premature rupture of membranes.
a Values are given as mean ± SD or number (percentage) unless otherwise indicated.
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dergone amniocentesis within 3 days prior to ultrasound-indicated
cerclage placement between January 1, 2008, and December 31, 2011,
at Hutzel Women’s Hospital at the Detroit Medical Center/Wayne
State University, Detroit, MI, USA, and subsequently presented with a
diagnosis of PPROM. The institutional review board at Wayne State
University approved the analysis before the study began. Informed
consent was obtained when the procedures were performed.
Data were abstracted based on a review of paired obstetric and neo-
natal medical records. The study group consisted of women in whom
the cerclage was retained for more than 12 hours after PPROM; the
comparison group comprised women who underwent immediate
cerclage removal after PPROM.
Amniocentesis was performed secondary to risk factors for preterm
birth, such as short cervix, preterm labor contractions, and previous pre-
term history. In all patients, cerclage placementwas performed because
of ultrasound-indicated shortening of the cervix (defined as cervical
length b25 mmwith a history of preterm birth) [10,11].
Amniotic fluid specimens were sent for Gram staining; mycoplasmic,
aerobic, and anaerobic bacteria cultures; and WBC, glucose, and IL-6
concentration assays to rule out infection and/or inflammation. Rescue
cervical cerclage was performed between 17 and 23 weeks of gestation.
McDonald cerclage was performed in all cases, using a 5-mmnonabsorb-
able polyester suture (Mersilene; Ethicon, Somerville, NJ, USA) in the
cervical–vaginal junction [12]. None of the patients received antibiotics
prior to amniocentesis or at the time of cerclage. Diagnosis of PPROM
was via direct visualization of fluid (pooling) in the posterior vaginal for-
nix during sterile speculumexamination, togetherwith positive confirma-
tory tests (e.g. nitrazine test) on cervicovaginal swab, presence of
arborization (ferning), andultrasonographic diagnosis of oligohydramnios
[13]. Patients received antibiotics after 24 weeks of pregnancy to prolong
latency periods and provide fetal benefits [14,15]. Betamethasone for fetal
lungmaturitywas administered at 24–32 weeks for patientswith PPROM
or imminent risk of preterm delivery [16,17]. 17α-Hydroxyprogesterone
caproate was started at 16–20 weeks in all women with prior preterm
birth for the prevention of prematurity [18,19]. Tocolytics and
transabdominal amnioinfusion were not administered.
The outcomes addressed were latency period from PPROM to deliv-
ery, histologic chorioamnionitis, gestational age at time of delivery,
latency period of more than 48 hours after PPROM, latency period of
more than 7 days after PPROM, perinatal mortality, neonatal birth
weight, neonatal sepsis, and cumulative neonatal morbidity. Cumulative
neonatal morbidity was defined as sepsis, respiratory distress syndrome,
pneumonia, bronchopulmonary dysplasia, intraventricular hemorrhage,
or necrotizing enterocolitis.
Statistical analyses were performed using SPSS version 17.0 (IBM,
Armonk, NY, USA). The t test, χ2 test, and Spearman correlation coeffi-
cient were used in the statistical analysis. P b 0.05 was considered to
be statistically significant.
3. Results
The total study population for clinically indicated amniocentesis and
cerclage included 127 cases. There were 87 exclusions: 55 patients did
not have a clear diagnosis of PPROM; 2 patients had positive amniotic
fluid cultures; 11 patients had twin ormultiple pregnancies; and placen-
tal histologywas absent for 19 patients. The remaining 40 cases involved
singleton pregnancies with negative amniotic fluid cultures and subse-
quent cerclage placement followed by PPROM. The study group con-
sisted of 18 women with retained cerclage; the comparison group
consisted of 22 women who underwent immediate cerclage removal.
The 2 groupswere similar in terms of the selected demographic char-
acteristics (Table 1), and the data were normally distributed. There were
36 African American patients, 3 white patients, and 1 Hispanic patient.
The 2 groups had similar concentrations of inflammatory markers in
amnioticfluid (Table 2). Cerclage retentionwas associatedwith a latencyperiod of more than 48 hours (61.1% in the study group vs 9.1% in the
comparison group; relative risk [RR] 6.7; 95% confidence interval [CI],
1.6–9.4; P b 0.001); a latency period of more than 7 days (31.7% vs
2.5%; RR 12.6; 95% CI, 1.7–24.1; P b 0.01); and chorioamnionitis (99.9%
vs 59.1%; RR 1.7; 95% CI, 1.4–3.1; P b 0.05). The latency period from
PPROM to delivery was significantly shorter in the removal group than
in the retention group (P b 0.005) (Table 3). There were no significant
differences between the groups in the other pregnancy and neonatal
outcomes (Table 4).
A sub-analysis of the relationship between inflammatorymarkers in
amniotic fluid and pregnancy/neonatal outcomes revealed that high
IL-6 concentrations were associated with a higher risk of cumulative
neonatal morbidity (50% in presence of cumulative neonatal morbidity
vs 1% in absence; RR 50; 95% CI, 14.2–66.5; P b 0.05) (Table 5). Low IL-6
concentrations were associated with a latency period of more than
7 days (21.7% in presence of latency period N7 days vs 2.5% in absence;
RR 8.7; 95% CI, 2.4–12.6; P b 0.001), as were low WBC concentrations
(87.5% in presence of latency period N7 days vs 12.5% in absence; RR
7; 95% CI, 4.02–11.6; P b 0.05). There were no other significant associa-
tions between pregnancy/neonatal outcomes and concentrations of
inflammatory markers in amniotic fluid (Table 6).
4. Discussion
The acute management of PPROM in the absence of indications for
delivery is expectant and requires the use of latency antibiotics to
prolong pregnancy and reduce neonatal morbidity [20]. However, the
Table 5
Sub-analysis of relationship between concentration of inflammatory markers in amniotic
fluid and neonatal outcomes.a
Outcome Interleukin-6,
ng/mL
White blood cells,
cells/mm3
Glucose,
mg/dL
Perinatal mortality
Present (n = 19) 31.45 ± 23.9 23.45 ± 15.3 29.56 ± 35.2
Absent (n = 21) 17.64 ± 26.3 21.6 ± 18.21 30.15 ± 29.9
P value 0.891 0.766 0.862
Cumulative neonatal morbidity
Present (n = 12) 34.35 ± 44.3 25.33 ± 29.6 26.51 ± 18.9
Absent (n = 28) 0.92 ± 0.859 17.45 ± 37.8 29.95 ± 24.9
P value 0.018 0.284 0.446
Neonatal sepsis
Present (n = 8) 28.15 ± 27.1 31.23 ± 17.3 29.56 ± 35.5
Absent (n = 32) 21.78 ± 26.1 29.76 ± 19.2 34.01 ± 30.1
P value 0.375 0.798 0.630
a Values are given as mean ± SD unless otherwise indicated.
Table 4
Neonatal outcomes.a
Outcome Removal (n = 22) Retention (n = 18) P value
Birth weight, g 1147.18 ± 832.1 903.72 ± 575.4 0.300
Perinatal mortality 10 (45.4) 9 (50.0) 0.775
Cumulative neonatal morbidity 7 (31.8) 5 (27.7) 0.952
Neonatal sepsis 5 (22.7) 3 (16.6) 0.891
a Values are given as mean ± SD or number (percentage) unless otherwise indicated.
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after PPROM has yet to be properly evaluated.
In their 2010 systematic review, Walsh et al. [21] reported that the
benefits of retaining a cerclage in situ with a ruptured membrane
were unclear. However, the review was based on a few relatively
small retrospective and underpowered studies (level II evidence).
In 2011, Giraldo-Isaza and Berghella [22] published a review of the
existing literature, comparing retention and removal of cervical cerclage
after PPROM. The authors concluded that cerclage retention for more
than 24 hours after PPROM prolonged pregnancy for more than
48 hours but also increased maternal chorioamnionitis and neonatal
mortality from sepsis, making immediate cerclage removal preferable
inmost cases as a therapeutic approach. The authors also recommended
the use of steroids for expediting fetal maturity before cerclage removal
between 24 and 33 + 6 weeks of gestation. The most interesting pro-
posed management was the use of amniocentesis to rule out infection.
The goal of the present study was to determine whether amniocen-
tesis could aid the clinical decision of whether to remove or retain aTable 6
Sub-analysis of relationship between concentration of inflammatory markers in amniotic
fluid and pregnancy outcomes.a
Outcome Interleukin-6,
ng/mL
White blood cells,
cells/mm3
Glucose,
mg/dL
Latency period of N48 hours after PPROM
Present (n = 13) 21.32 ± 26.4 16.07 ± 19.2 31.35 ± 10.1
Absent (n = 27) 23.04 ± 28.3 25.6 ± 21.2 29.1 ± 20.8
P value 0.891 0.065 0.698
Latency period of N7 days after PPROM
Present (n = 7) 0.70. ± 0.45 4.80 ± 6.611 30.5 ± 14.9
Absent (n = 33) 25.41 ± 31.4 21.83 ± 25.6 38.45 ± 24.4
P value b0.001 0.031 0.521
Histologic chorioamnionitis
Present (n = 8) 20.1 ± 10.9 34.8 ± 15.4 30.3 ± 9.23
Absent (n = 32) 12.72 ± 38.2 29.62 ± 23.2 32.8 ± 21.5
P value 0.062 0.073 0.689
Abbreviation: PPROM, preterm premature rupture of membranes.
a Values are given as mean ± SD unless otherwise indicated.cerclage after PPROM. In the present study, cerclage retention prolonged
the latency period after PPROM but it did not have a significant effect
on neonatal outcome. However, sub-analysis revealed that elevated
amniotic IL-6 concentrations were associated with neonatal morbidity
and that low amniotic IL-6 and WBC concentrations were associated
with a latency period of more than 7 days.
The limitations of the present study were its relatively small
sample size and its retrospective nature, which increased the risk
of bias.
In summary, the present results indicate that measurement of IL-6
andWBC levels in amniotic fluid may be of clinical value for individual-
izing the management of patients with PPROM after cervical cerclage
placement. The results of the study solidify our previous recommenda-
tion [9] of amniocentesis prior to rescue cerclage because of the capacity
of inflammatory markers in the amniotic fluid to identify patients who
would benefit from cerclage and to detect subclinical infections that
might otherwise compromise fetal status if PPROM occurred and the
cerclage were retained. Furthermore, because the physiologies of uter-
ine contractions and cervical shortening, as well as the techniques
used for cerclage placement and amniocentesis, are similar among
women of all races and ethnicities, the conclusions of the present
study may be applicable globally.Conflict of interest
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